IFRX logo

InflaRx NV (IFRX)

Profile

Full Name

InflaRx N.V.

Ticker Symbol

IFRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

November 7, 2017

Indexes

Not included

Website

http://www.inflarx.de

Employees

74

Key Details

Price

$1.03(-5.91%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$179.40K(+162.66% YoY)

Annual EPS

-$0.84(+0.02% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.03
IFRX price is $1.03

30-Day Relative Volume

1.04
IFRX 30-day relative volume is 1.04

Price Performance

Price Today change

-5.91%
IFRX price is down -5.91% today

Price YTD change

-58.1%
IFRX price is down -58.1% since January 1st

Price 1-year change

-20.99%
IFRX price is down -20.99% year-on-year

Price 3-year change

-42.5%
IFRX price is down -42.5% over the past 3 years

Price Range

Price All-time high

$53.10
IFRX price is currently -98.05% below its historical high of $53.10

Price 3-year low

$0.78
IFRX price is currently +33.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$69.48M
IFRX market capitalization is $69.48 million

Market cap 3-year change

-12.67%
IFRX market capitalization is down -12.67% over the past 3 years

Market cap All-time high

$1.34B
IFRX market capitalization is currently -94.81% below its historical high of $1.34 billion

Market cap sector rank

42.93%
IFRX market capitalization is higher than 42.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+14.01%
IFRX shares outstanding is up +14.01% year-on-year

Shares Outstanding 3-Year Change

+51.87%
IFRX shares outstanding is up +51.87% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.66
IFRX beta is 0.66

200-day SMA

$1.73
IFRX price is currently -40.24% below its 200-day simple moving average

50-day SMA

$1.48
IFRX price is currently -30.01% below its 50-day simple moving average

RSI

45.29
IFRX 14-day relative strength index is 45.29

Volume

1.04
IFRX 30-day relative volume is 1.04

ATR

$0.13
IFRX average true range is $0.13

10-day Historical Volatility

110.23%
IFRX 10-day historical volatility is 110.23%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$179.40K
IFRX annual revenue is $179.40 thousand

Revenue Analysts estimate

$252.00K
IFRX annual revenue is currently -28.81% lower than the consensus analysts' forecast

Revenue 1-year change

+162.66%
IFRX annual revenue is up +162.66% year-on-year

Revenue Sector rank

6.93%
IFRX annual revenue is higher than 6.93% of companies in Healthcare sector

EPS

EPS

-$0.84
IFRX annual earnings per share is -$0.84

EPS Analysts estimate

-$0.58
IFRX annual earnings per share is currently +44.73% higher than the consensus analysts' forecast

EPS 1-year change

+0.02%
IFRX annual earnings per share is up +0.02% year-on-year

EPS Sector rank

60.31%
IFRX annual earnings per share is higher than 60.31% of companies in Healthcare sector

Profit

Gross profit

-$3.41M
IFRX annual gross profit is -$3.41 million

Gross margin

-1900.76%
IFRX annual gross profit margin is -1900.76%

Operating profit

-$57.37M
IFRX annual operating income is -$57.37 million

Operating margin

-31.97K%
IFRX annual operating profit margin is -31.97 thousand%

Net income

-$49.86M
IFRX annual net profit is -$49.86 million

Net margin

-27.78K%
IFRX annual net profit margin is -27.78 thousand%

Expenses

Total expenses

$57.55M
IFRX annual total expenses is $57.55 million

Operating expenses

$53.96M
IFRX annual total operating expenses is $53.96 million

Cost of goods sold

$3.59M
IFRX annual cost of goods sold is $3.59 million

Selling, general & administrative expenses

$20.92M
IFRX annual SGA is $20.92 million

Depreciation and amortization

$525.10K
IFRX annual depreciation & amortization is $525.10 thousand

Interest expense

$22.40K
IFRX annual interest expense is $22.40 thousand

Income tax

$5600.00
IFRX annual income tax is $5600.00

EBIT & EBITDA

EBIT

-$49.83M
IFRX annual earnings before interest & taxes is -$49.83 million

EBITDA

-$49.30M
IFRX annual EBITDA is -$49.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$79.10M
IFRX annual total assets is $79.10 million

Non current assets

$4.54M
IFRX annual long term assets is $4.54 million

Current assets

$74.56M
IFRX annual total current assets is $74.56 million

Cash and cash equivalents

$19.12M
IFRX annual cash & cash equivalents is $19.12 million

Accounts receivable

-
IFRX annual accounts receivable value is unknown

Inventory

$7.18M
IFRX annual inventory is $7.18 million

Liabilities

Total liabilities

$15.19M
IFRX annual total liabilities is $15.19 million

Long term liabilities

$453.60K
IFRX annual total long term liabilities is $453.60 thousand

Current liabilities

$14.74M
IFRX annual total current liabilities is $14.74 million

Accounts payable

$11.86M
IFRX annual accounts payable is $11.86 million

Debt

Total debt

$837.80K
IFRX annual total debt is $837.80 thousand

Total debt 1-year change

-32.33%
IFRX annual total debt is down -32.33% year-on-year

Long term debt

$415.30K
IFRX annual long term debt is $415.30 thousand

Short term debt

$422.50K
IFRX annual short term debt is $422.50 thousand

Equity & Capital

Shareholders equity

$63.91M
IFRX annual stockholders equity is $63.91 million

Book value

$63.91M
IFRX annual book value is $63.91 million

Retained earnings

-$345.67M
IFRX annual retained earnings is -$345.67 million

Working capital

$59.82M
IFRX annual working capital is $59.82 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$52.56M
IFRX annual cash flow from operations is -$52.56 million

Cash from operations 1-year change

-28.38%
IFRX annual cash flow from operations is down -28.38% year-on-year

Cash from investing

$56.68M
IFRX annual cash flow from investing activities is $56.68 million

Cash from investing 1-year change

+395.83%
IFRX annual cash flow from investing activities is up +395.83% year-on-year

Cash from financing

$418.30K
IFRX annual cash flow from financing activities is $418.30 thousand

Cash from financing 1-year change

-99.27%
IFRX annual cash flow from financing activities is down -99.27% year-on-year

CAPEX

CAPEX

$50.70K
IFRX annual capital expenditures is $50.70 thousand

CAPEX 1-year change

-42.26%
IFRX annual capital expenditures is down -42.26% year-on-year

Free Cash Flow

Free cash flow

-$52.61M
IFRX annual free cash flow is -$52.61 million

Free cash flow 1-year change

-28.23%
IFRX annual free cash flow is down -28.23% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-1900.76%
IFRX annual gross profit margin is -1900.76%

Operating margin

-31.97K%
IFRX annual operating profit margin is -31.97 thousand%

Net margin

-27.78K%
IFRX annual net profit margin is -27.78 thousand%

ROA & ROE

ROA

-47.04%
IFRX annual return on assets is -47.04%

ROE

-56.24%
IFRX annual return on equity is -56.24%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IFRX price to earnings ratio value is unknown

PE ratio Sector rank

-
IFRX price to earnings ratio is unknown

PB Ratio

PB ratio

1.09
IFRX price to book ratio is 1.09

PB ratio Sector rank

46.17%
IFRX price to book ratio is higher than 46.17% of companies in Healthcare sector

PS Ratio

PS ratio

382.62
IFRX price to sales ratio is 382.62

PS ratio Sector rank

97.44%
IFRX price to sales ratio is higher than 97.44% of companies in Healthcare sector

Enterprise value

Enterprise value

$51.20M
IFRX enterprise value is $51.20 million

Enterprise value Sector rank

42.02%
IFRX enterprise value is higher than 42.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.03
IFRX EV/EBITDA is -1.03

EV/EBITDA Sector rank

42.12%
IFRX EV/EBITDA is higher than 42.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.06
IFRX annual current ratio is 5.06

Quick ratio

4.57
IFRX annual quick ratio is 4.57

Leverage

Debt to equity

0.00
IFRX annual debt to equity ratio is 0.00

Interest coverage ratio

-2224.54
IFRX annual interest coverage ratio is -2224.54

Risk & Stability

Piotroski F-Score

2
IFRX piotroski f-score is 2

Altman Z-Score

-4.54
IFRX altman z-score is -4.54

Analyst ratings

Recent major analysts updates

Mar 26, 25 Guggenheim
Buy
Mar 21, 25 HC Wainwright & Co.
Buy
Mar 7, 25 HC Wainwright & Co.
Buy
Jan 16, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Sep 25, 24 HC Wainwright & Co.
Buy
Jun 24, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Alpha Cognition (ACOG)
XCUR logo
Exicure (XCUR)
IMAB logo
I-Mab (IMAB)
ASMB logo
Assembly Biosciences (ASMB)
TCRX logo
TScan Therapeutics (TCRX)
CRBP logo
Corbus Pharmaceuticals Holdings (CRBP)
NSPR logo
InspireMD (NSPR)
CARA logo
Cara Therapeutics (CARA)
MLSS logo
Milestone Scientific (MLSS)
  • What is the ticker symbol for InflaRx NV?
  • Does InflaRx NV pay dividends?
  • What sector is InflaRx NV in?
  • What industry is InflaRx NV in?
  • What country is InflaRx NV based in?
  • When did InflaRx NV go public?
  • Is InflaRx NV in the S&P 500?
  • Is InflaRx NV in the NASDAQ 100?
  • Is InflaRx NV in the Dow Jones?
  • When was InflaRx NV's last earnings report?
  • When does InflaRx NV report earnings?

What is the ticker symbol for InflaRx NV?

The ticker symbol for InflaRx NV is NASDAQ:IFRX

Does InflaRx NV pay dividends?

No, InflaRx NV does not pay dividends

What sector is InflaRx NV in?

InflaRx NV is in the Healthcare sector

What industry is InflaRx NV in?

InflaRx NV is in the Biotechnology industry

What country is InflaRx NV based in?

InflaRx NV is headquartered in Germany

When did InflaRx NV go public?

InflaRx NV's initial public offering (IPO) was on November 7, 2017

Is InflaRx NV in the S&P 500?

No, InflaRx NV is not included in the S&P 500 index

Is InflaRx NV in the NASDAQ 100?

No, InflaRx NV is not included in the NASDAQ 100 index

Is InflaRx NV in the Dow Jones?

No, InflaRx NV is not included in the Dow Jones index

When was InflaRx NV's last earnings report?

InflaRx NV's most recent earnings report was on Mar 20, 2025

When does InflaRx NV report earnings?

The next expected earnings date for InflaRx NV is May 8, 2025
On this page